A policy approach to the development of molecular diagnostic tests

Nature Biotechnology

Volumn 28, Issue 11, 2010, Pages 1157-1159

  Schulman, Kevin A ^a   Tunis, Sean R ^b  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b Center for Medical Technology Policy   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COST CONTROL; DECISION MAKING; DIAGNOSTIC PROCEDURE; FOOD AND DRUG ADMINISTRATION; MEDICAL TECHNOLOGY; MEDICARE; NOTE; POLICY; PRIORITY JOURNAL; REIMBURSEMENT; UNITED STATES;

BIOLOGICAL MARKERS; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; POLICY; REIMBURSEMENT MECHANISMS; UNITED STATES;

EID: 78149301242     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt1110-1157     Document Type: Note

References (16)

1. U.S.C. § 1395 (1)
2. Tunis, S.R. N. Engl. J. Med. 350, 2196-2198 (2004).
3. Potti, A. et al. N. Engl. J. Med. 355, 570-580 (2006).
4. Acharya, C.R. et al. J. Am. Med. Assoc. 299, 1574-1587 (2008).
5. Paik, S. et al. J. Clin. Oncol. 24, 3726-3734 (2006).
6. Evans, W.E. & McLeod, H.L. N. Engl. J. Med. 348, 538-549 (2003).
7. Bild, A.H. et al. Nature 439, 353-357 (2006).
8. Rieder, M.J. et al. N. Engl. J. Med. 352, 2285-2293 (2005).
9. Liu, R. et al. N. Engl. J. Med. 356, 217-226 (2007).
10. Glickman, S.W. et al. N. Engl. J. Med. 360, 816-823 (2009).
11. Modan, B. et al. N. Engl. J. Med. 345, 235-240 (2001).
12. Anonymous. (USDHHS, CMS, Baltimore, MD, USA) (Accessed May 14, 2008).
13. Kolata, G. Medicare covering new treatments, but with a catch. New York Times (5 November, 2004).
14. Tunis, S.R. & Pearson, S.D. Health Aff. 25, 1218-1230 (2006).
15. Reed, S.D., Shea, A.M. & Schulman, K.A. J. Gen. Intern. Med. 23 Suppl 1, 50-56 (2008).
16. Ackerly, D.C., Valverde, A.M., Diener, L.W., Dossary, K.L. & Schulman, K.A. Health Aff. 28, w68-w75 (2009).